Leaflet DOBUTAMINA HAMELN 5mg / ml solution for infusion


Indicated for: cardiogenic shock; acute heart failure

Substance: dobutamine (vasopressor)

ATC: C01CA07 (Cardiovascular system | Cardiac stimulants excluding cardiac glycosides | Adrenergic and dopaminergic agents)

Dobutaminum is a medication used for the treatment of acute heart failure and other conditions requiring increased cardiac contractility. It is a beta-adrenergic agonist that stimulates the heart to pump blood more efficiently.

The medication is administered intravenously, usually in a hospital setting, under medical supervision. It is effective in improving cardiac function and stabilizing patients with severe heart failure.

Side effects may include tachycardia, high blood pressure, nausea, and, in rare cases, arrhythmias. Close monitoring of cardiac function is essential during treatment.

Consult your doctor to discuss the benefits and risks of treatment with Dobutaminum. This medication must be administered exclusively in controlled environments, such as hospitals.

General data about DOBUTAMINA HAMELN 5mg / ml

  • Substance: dobutamine
  • Date of last drug list: 01-05-2026
  • Commercial code: W68022001
  • Concentration: 5mg / ml
  • Pharmaceutical form: solution for infusion
  • Quantity: 1
  • Product type: generic
  • Price: 31.02 RON
  • Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

  • Manufacturer: SIEGFRIED HAMELN GMBH - GERMANIA
  • Holder: HAMELN PHARMA GMBH - GERMANIA
  • Number: 14733/2022/01
  • Shelf life: 3 years-after packing for marketing;dupa diluare-it is used immediately

Pharmaceutical forms available for dobutamine

Concentrations available for dobutamine

  • 12.5mg/ml
  • 125mg/ml
  • 250mg
  • 250mg/20ml
  • 250mg/50ml
  • 5mg/ml